Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Sep;36(9):1832–1836. doi: 10.1128/aac.36.9.1832

Effect of concomitant administration of piperacillin on the dispositions of isepamicin and gentamicin in patients with end-stage renal disease.

C E Halstenson 1, M O Wong 1, C S Herman 1, K L Heim-Duthoy 1, M A Teal 1, M B Affrime 1, J H Kelloway 1, W F Keane 1, W M Awni 1
PMCID: PMC192195  PMID: 1416875

Abstract

Piperacillin inactivation of the aminoglycosides isepamicin and gentamicin in 12 chronic hemodialysis patients was assessed. Six subjects each received isepamicin (7.5 mg/kg of body weight) or gentamicin (2 mg/kg) alone and in combination with piperacillin (4 g every 12 h for four doses). Isepamicin and gentamicin concentrations in plasma and urine were monitored over 48 h after each dose and analyzed by high-performance liquid chromatography and fluorescence polarization immunoassay, respectively. The pharmacokinetics of isepamicin were not significantly altered during combination treatment with piperacillin. The total body clearance (3.79 +/- 0.71 versus 3.94 +/- 1.05 ml/min), the steady-state volume of distribution (0.19 +/- 0.04 versus 0.18 +/- 0.03 liter/kg), and the terminal elimination half-life (47.91 +/- 7.20 versus 45.08 +/- 10.34 h) were not significantly altered in the presence of piperacillin. In contrast, the terminal elimination half-life (47.68 +/- 20.58 versus 35.67 +/- 11.18 h) of gentamicin was significantly reduced when gentamicin was given with piperacillin. The total body clearance (4.26 +/- 3.07 versus 4.89 +/- 1.94 ml/min) and the steady-state volume of distribution (0.19 +/- 0.04 versus 0.20 +/- 0.04 liter/kg) of gentamicin were not significantly altered during combination therapy; however, the nonrenal clearance of gentamicin administered in combination with piperacillin (3.56 +/- 0.38 ml/min) increased significantly compared with that of gentamicin (2.03 +/- 0.50 ml/min) given alone. The results of this study suggest that no additional dosage adjustment of isepamicin during concomitant therapy with piperacillin in hemodialysis patients is necessary. However, this does not preclude the need for appropriately ex vivo-handled specimens for monitoring isepamicin concentrations in plasma to ensure therapeutic efficacy and prevent toxicity. Furthermore, additional dosage adjustments may be necessary when gentamicin is used concomitantly with piperacillin, on the basis of the significant in vivo inactivation that takes place in end-stage renal disease patients.

Full text

PDF
1832

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blair D. C., Duggan D. O., Schroeder E. T. Inactivation of amikacin and gentamicin by carbenicillin in patients with end-stage renal failure. Antimicrob Agents Chemother. 1982 Sep;22(3):376–379. doi: 10.1128/aac.22.3.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brumfitt W., Percival A., Leigh D. A. Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea. Lancet. 1967 Jun 17;1(7503):1289–1293. doi: 10.1016/s0140-6736(67)91590-5. [DOI] [PubMed] [Google Scholar]
  3. Chanbusarakum P., Murray P. R. Analysis of the interactions between piperacillin, ticarcillin, or carbenicillin and aminoglycoside antibiotics. Antimicrob Agents Chemother. 1978 Sep;14(3):505–506. doi: 10.1128/aac.14.3.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Davies M., Morgan J. R., Anand C. Interactions of carbenicillin and ticarcillin with gentamicin. Antimicrob Agents Chemother. 1975 Apr;7(4):431–434. doi: 10.1128/aac.7.4.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ervin F. R., Bullock W. E., Jr, Nuttall C. E. Inactivation of gentamicin by penicillins in patients with renal failure. Antimicrob Agents Chemother. 1976 Jun;9(6):1004–1011. doi: 10.1128/aac.9.6.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Flournoy D. J. Factors influencing the inactivation of aminoglycosides by beta-lactams. Methods Find Exp Clin Pharmacol. 1979 Oct;1(4):233–238. [PubMed] [Google Scholar]
  7. Giamarellou H. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions. Am J Med. 1986 Jun 30;80(6B):126–137. doi: 10.1016/0002-9343(86)90490-0. [DOI] [PubMed] [Google Scholar]
  8. Halstenson C. E., Hirata C. A., Heim-Duthoy K. L., Abraham P. A., Matzke G. R. Effect of concomitant administration of piperacillin on the dispositions of netilmicin and tobramycin in patients with end-stage renal disease. Antimicrob Agents Chemother. 1990 Jan;34(1):128–133. doi: 10.1128/aac.34.1.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Halstenson C. E., Kelloway J. S., Affrime M. B., Lin C. C., Teal M. A., Shapiro B. E., Awni W. M. Isepamicin disposition in subjects with various degrees of renal function. Antimicrob Agents Chemother. 1991 Nov;35(11):2382–2387. doi: 10.1128/aac.35.11.2382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Henderson J. L., Polk R. E., Kline B. J. In vitro inactivation of gentamicin, tobramycin, and netilmicin by carbenicillin, azlocillin, or mezlocillin. Am J Hosp Pharm. 1981 Aug;38(8):1167–1170. [PubMed] [Google Scholar]
  11. Holt H. A., Broughall J. M., McCarthy M., Reeves D. S. Interactions between aminoglycoside antibiotics and carbenicillin or ticarillin. Infection. 1976;4(2):107–109. doi: 10.1007/BF01638726. [DOI] [PubMed] [Google Scholar]
  12. Konishi H., Goto M., Nakamoto Y., Yamamoto I., Yamashina H. Tobramycin inactivation by carbenicillin, ticarcillin, and piperacillin. Antimicrob Agents Chemother. 1983 May;23(5):653–657. doi: 10.1128/aac.23.5.653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kradjan W. A., Burger R. In vivo inactivation of gentamicin by carbenicillin and ticarcillin. Arch Intern Med. 1980 Dec;140(12):1668–1670. [PubMed] [Google Scholar]
  14. Lau A., Lee M., Flascha S., Prasad R., Sharifi R. Effect of piperacillin on tobramycin pharmacokinetics in patients with normal renal function. Antimicrob Agents Chemother. 1983 Oct;24(4):533–537. doi: 10.1128/aac.24.4.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lumish R. M., Norden C. W. Therapy of neutropenic rats infected with Pseudomonas aeruginosa. J Infect Dis. 1976 May;133(5):538–547. doi: 10.1093/infdis/133.5.538. [DOI] [PubMed] [Google Scholar]
  16. Maloney J. A., Awni W. M. High-performance liquid chromatographic determination of isepamicin in plasma, urine and dialysate. J Chromatogr. 1990 Apr 6;526(2):487–496. doi: 10.1016/s0378-4347(00)82530-x. [DOI] [PubMed] [Google Scholar]
  17. Matzke G. R., Luckham D. R., Collins A. J., Halstenson C. E. Effect of ticarcillin on gentamicin and tobramycin pharmacokinetics in a patient with end-stage renal disease. Pharmacotherapy. 1984 May-Jun;4(3):158–160. doi: 10.1002/j.1875-9114.1984.tb03342.x. [DOI] [PubMed] [Google Scholar]
  18. McLaughlin J. E., Reeves D. S. Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin. Lancet. 1971 Feb 6;1(7693):261–264. doi: 10.1016/s0140-6736(71)91001-4. [DOI] [PubMed] [Google Scholar]
  19. Noone P., Pattison J. R. Therapeutic implications of interaction of gentamicin and penicillins. Lancet. 1971 Sep 11;2(7724):575–578. doi: 10.1016/s0140-6736(71)92152-0. [DOI] [PubMed] [Google Scholar]
  20. Pickering L. K., Gearhart P. Effect of time and concentration upon interaction between gentamicin, tobramycin, Netilmicin, or amikacin and carbenicillin or ticarcillin. Antimicrob Agents Chemother. 1979 Apr;15(4):592–596. doi: 10.1128/aac.15.4.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pickering L. K., Rutherford I. Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin. J Pharmacol Exp Ther. 1981 May;217(2):345–349. [PubMed] [Google Scholar]
  22. Riff L. J., Jackson G. G. Laboratory and clinical conditions for gentamicin inactivation by carbenicillin. Arch Intern Med. 1972 Dec;130(6):887–891. [PubMed] [Google Scholar]
  23. Russo M. E., Atkin-Thor E. Gentamicin and ticarcillin in subjects with end-stage renal disease. Comparison of two assay methods and evaluation of inactivation rate. Clin Nephrol. 1981 Apr;15(4):175–180. [PubMed] [Google Scholar]
  24. Thompson M. I., Russo M. E., Saxon B. J., Atkin-Thor E., Matsen J. M. Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease. Antimicrob Agents Chemother. 1982 Feb;21(2):268–273. doi: 10.1128/aac.21.2.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Waitz J. A., Drube C. G., Moss E. L., Jr, Oden E. M., Bailey J. V. Biological aspects of the interaction between gentamicin and carbenicillin. J Antibiot (Tokyo) 1972 Apr;25(4):219–225. doi: 10.7164/antibiotics.25.219. [DOI] [PubMed] [Google Scholar]
  26. Walterspiel J. N., Feldman S., Van R., Ravis W. R. Comparative inactivation of isepamicin, amikacin, and gentamicin by nine beta-lactams and two beta-lactamase inhibitors, cilastatin and heparin. Antimicrob Agents Chemother. 1991 Sep;35(9):1875–1878. doi: 10.1128/aac.35.9.1875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Weibert R., Keane W., Shapiro F. Carbenicillin inactivation of aminoglycosides in patients with severe renal failure. Trans Am Soc Artif Intern Organs. 1976;22:439–443. [PubMed] [Google Scholar]
  28. Weiner D. L. NONLIN84/PCNONLIN: software for the statistical analysis of nonlinear models. Methods Find Exp Clin Pharmacol. 1986 Oct;8(10):625–628. [PubMed] [Google Scholar]
  29. White G. W., Malow J. B., Zimelis V. M., Pahlavanzadeh H., Panwalker A. P., Jackson G. G. Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside. Antimicrob Agents Chemother. 1979 Apr;15(4):540–543. doi: 10.1128/aac.15.4.540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Winters R. E., Chow A. W., Hecht R. H., Hewitt W. L. Combined use of gentamicin and carbenicillin. Ann Intern Med. 1971 Dec;75(6):925–927. doi: 10.7326/0003-4819-75-6-925. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES